Clinical Trials List
2016-02-01 - 2020-06-30
Phase III
Terminated2
ICD-10C34
Malignant neoplasm of bronchus and lung
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
BRISTOL-MYERS SQUIBB (TAIWAN) LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Wen-Pin Su Division of Hematology & Oncology
- Wei-Pang Chung Division of Hematology & Oncology
- Yu-Min Yeh Division of Hematology & Oncology
- Sin-Syue Li Division of Hematology & Oncology
- Shang-Yin Wu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Audit
None
Co-Principal Investigator
- Cheng-Ta Yang Division of Hematology & Oncology
- 林倡葦 Division of Hematology & Oncology
- Chih-Hung Chen Division of Hematology & Oncology
- 李忠恕 Division of Hematology & Oncology
- Chih-Hung Chen Division of Hematology & Oncology
- Shih-Hong Li Division of Hematology & Oncology
- 謝任富 Division of Hematology & Oncology
- Chien-Ying Liu Division of Hematology & Oncology
- Chih-Liang Wang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
1 Terminated
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
810 participants
